OTC Markets EXMKT - Delayed Quote USD
Aridis Pharmaceuticals, Inc. (ARDS)
0.0001
0.0000
(0.00%)
At close: May 8 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| HAMILTON JOHN F Director | Conversion of Exercise of derivative security | Jun 5, 2023 | 5,000 |
| JAFRI HASAN Officer | Conversion of Exercise of derivative security | Jun 5, 2023 | 15,100 |
| KURLAND FRED F Chief Financial Officer | Conversion of Exercise of derivative security | Jun 5, 2023 | 4,000 |
| PATZER ERIC Director | Purchase | Jun 24, 2024 | 884,600 |
| TRUONG VU Chief Executive Officer | Purchase | Jun 24, 2024 | 1,378,640 |
| WINDHAM-BANNISTER SUSAN RICHARDS Director | Conversion of Exercise of derivative security | Jun 5, 2023 | 5,000 |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
1.2100
-3.97%
SNGX Soligenix, Inc.
1.9700
0.00%
IGMS IGM Biosciences, Inc.
1.1300
-0.88%
OTLC Oncotelic Therapeutics, Inc.
0.0600
0.00%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
PALI Palisade Bio, Inc.
0.7649
-1.66%
NLSP NLS Pharmaceutics AG
1.6500
0.00%
BCDA BioCardia, Inc.
2.8500
+7.95%
LVTX LAVA Therapeutics N.V.
1.2700
+1.60%
JUNS Jupiter Neurosciences, Inc.
0.6248
-0.35%